UroGen Pharma saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of UroGen Pharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
UroGen Pharma has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 100% grants. The United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where UroGen Pharma is filings its patents. Among the top granted patent authorities, UroGen Pharma has 100% of its grants in United States(US).
AbbVie and Roche could be the strongest competitors for UroGen Pharma
Patents related to rare diseases lead UroGen Pharma's portfolio
UroGen Pharma has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Cervical cancer related patents lead UroGen Pharma portfolio followed by human papillomavirus infections, and caries
UroGen Pharma has highest number of patents in cervical cancer followed by human papillomavirus infections, caries, carcinomas, and adenocarcinoma.
For comprehensive analysis of UroGen Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
